Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Noster Inc. maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The current prosecution landscape is defined by 1 pending office action, which is situated within 1 distinct art unit. This concentration suggests a specific technical focus for the company's current intellectual property efforts.
The portfolio involves 1 distinct examiner, identified as ROBERT JAMES KALLAL. This individual serves as the busiest examiner for the company with 1 busiest examiner pending action. Because the 1 pending office action is handled by the 1 distinct examiner, the company faces a centralized prosecution environment. This structure means that the outcome of the pending matter depends entirely on the interactions within the art unit. Practitioners can observe that the workload is not distributed, as the 1 busiest examiner pending action accounts for the total pending volume. The presence of the art unit indicates that the portfolio is not currently branching into diverse regulatory or technical classifications at the patent office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KALLAL, ROBERT JAMES | 1 | 60.0% | +32.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17621856 | BACTERIAL SUPPLYING SYSTEM | KALLAL, ROBERT JAMES | 63d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17621856 | BACTERIAL SUPPLYING SYSTEM | KALLAL, ROBERT JAMES | 63d |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17621856 | BACTERIAL SUPPLYING SYSTEM | KALLAL, ROBERT JAMES | 1685 | §101§103§112 | Final Rejection | 63d | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial